Washington University School of Medicine in St. Louis | Washington University Therapeutics (WT) CRS
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Washington University School of Medicine in St. Louis
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Contact ID CRU about Studies
Verified by this site
Active trials
This study is open to adults who are at least 18 years old and have* a body mass index (BMI) of 30 kg/m² or more, or* a BMI of 27 kg/m² or more and a...
This study will evaluate the safety and efficacy of the injectable drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected...
A phase II, randomized, open-label, two-arm clinical trial evaluating the safety and efficacy of pramipexole extended release (ER) versus escitalopra...
The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly...
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-co...
The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub...
Trial sponsors
Clinical trials
Research sites
Resources
Legal